124
Pill imprint 124 has been identified as Pantoprazole sodium delayed release 40 mg.
Pantoprazole is used in the treatment of stomach ulcer; gerd; peptic ulcer; erosive esophagitis; barrett's esophagus (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy.
Pantoprazole 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Pantoprazole sodium delayed release Images
- Imprint:
-
124
- Strength:
- 40 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 62756-0580
| NDC Code | Manufacturer / Repackager |
|---|---|
| 41616-0580 | Sun Pharmaceutical Industries Ltd |
| 68084-0283 | Amerisource Health Services |
| 54569-6062 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Pantoprazole Sodium Delayed Release resources
- Pantoprazole (Wolters Kluwer)
- Pantoprazole Delayed-Release Tablets (Wolters Kluwer)
- Pantoprazole Suspension (Wolters Kluwer)
- pantoprazole (Cerner Multum)
- pantoprazole (Micromedex) - Includes Dosage Information
- pantoprazole Intravenous (Micromedex) - Includes Dosage Information
- Pantoprazole Sodium (AHFS DI)
- Pantoprazole (FDA)
- Protonix Tablets (FDA)
- Pantoprazole Sodium (Wolters Kluwer)
Search Again
